Lombard Odier Asset Management (Europe)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-34,053
Closed -$8.79M 167
2025
Q2
$8.79M Sell
34,053
-45
-0.1% -$10.7K 0.62% 59
2025
Q1
$7.63M Sell
34,098
-12,500
-27% -$2.92M 0.61% 59
2024
Q4
$10.7M Sell
46,598
-22,574
-33% -$5.44M 0.69% 40
2024
Q3
$16.9M Sell
69,172
-30,631
-31% -$6.84M 0.72% 35
2024
Q2
$19.1M Buy
99,803
+46,816
+88% +$9.5M 0.9% 23
2024
Q1
$10.5M Buy
+52,987
New +$9.71M 0.63% 52
2023
Q2
Sell
-2,700
Closed -$591K 286
2023
Q1
$591K Hold
2,700
0.03% 245
2022
Q4
$562K Sell
2,700
-300
-10% -$65.9K 0.02% 254
2022
Q3
$655K Hold
3,000
0.03% 237
2022
Q2
$629K Buy
+3,000
New +$639K 0.03% 237
2021
Q2
Sell
-1,230
Closed -$239K 221
2021
Q1
$239K Buy
+1,230
New +$247K 0.01% 224
2020
Q4
Sell
-1,248
Closed -$214K 352
2020
Q3
$214K Buy
+1,248
New +$230K 0.01% 327
2020
Q1
Sell
-1,791
Closed -$278K 386
2019
Q4
$278K Hold
1,791
0.02% 312
2019
Q3
$242K Hold
1,791
0.02% 333
2019
Q2
$219K Buy
+1,791
New +$198K 0.02% 365
2019
Q1
Sell
-1,791
Closed -$204K 393
2018
Q4
$204K Buy
+1,791
New +$192K 0.02% 333

Other funds holding RMD

Lombard Odier Asset Management (Europe)'s RMD Position: Q3 2025 in Review

Lombard Odier Asset Management (Europe) sold out of ResMed (RMD) in Q3 2025, closing a stake of 34,053 shares — an estimated $8.79M sold.

Lombard Odier Asset Management (Europe) first reported a position in RMD in Q4 2018 and held it in 16 quarters. The position peaked at $19.1M in Q2 2024. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Lombard Odier Asset Management (Europe) reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 34,053 ResMed shares in Q3 2025, an estimated $8.79M.
  • Lombard Odier Asset Management (Europe) first reported a position in ResMed in Q4 2018 and held it in 16 quarters.
  • Lombard Odier Asset Management (Europe)'s ResMed position peaked at $19.1M in Q2 2024.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q3 2025, filed 14 Nov 2025.